awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q26996629-32F8E35C-20C7-4451-812C-EB91EDD8D0B8
Q26996629-32F8E35C-20C7-4451-812C-EB91EDD8D0B8
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26996629-32F8E35C-20C7-4451-812C-EB91EDD8D0B8
Systematic review and network meta-analysis of overall survival comparing 3 mg/kg ipilimumab with alternative therapies in the management of pretreated patients with unresectable stage III or IV melanoma
P2860
Q26996629-32F8E35C-20C7-4451-812C-EB91EDD8D0B8
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26996629-32F8E35C-20C7-4451-812C-EB91EDD8D0B8
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
be69cbad2d5ac08e764d1c5c0cd999cd32145663
P2860
Phase III trial comparing concurrent biochemotherapy with cisplatin, vinblastine, dacarbazine, interleukin-2, and interferon alfa-2b with cisplatin, vinblastine, and dacarbazine alone in patients with metastatic malignant melanoma (E3695): a trial c